Literature DB >> 9636573

Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.

B Ringe1, F Braun, T Lorf, R Canelo, E Schütz, B Sattler, G Ramadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636573     DOI： 10.1016/s0041-1345(98)00296-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

2.  A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.

Authors:  A Jain; R Kashyap; F Dodson; D Kramer; I Hamad; A Khan; B Eghestad; T E Starzl; J J Fung
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

3.  Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real-world data and simulated data.

Authors:  Michael L Williams; Hannah L Weeks; Cole Beck; Kelly A Birdwell; Sara L Van Driest; Leena Choi
Journal:  Br J Clin Pharmacol       Date:  2022-01-27       Impact factor: 3.716

Review 4.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.